Showing 1 - 5 results of 5 for search 'Nadezhda V. Antipova', query time: 0.04s
Refine Results
-
1
Liposomal Formulation of a PLA2-Sensitive Phospholipid–Allocolchicinoid Conjugate: Stability and Activity Studies In Vitro by Maria K. Kobanenko, Daria S. Tretiakova, Ekaterina S. Shchegravina, Nadezhda V. Antipova, Ivan A. Boldyrev, Alexey Yu. Fedorov, Elena L. Vodovozova, Natalia R. Onishchenko
Published 2022-01-01
Article -
2
Chelation of Zinc with Biogenic Amino Acids: Description of Properties Using Balaban Index, Assessment of Biological Activity on <i>Spirostomum Ambiguum</i> Cellular Biosensor, Inf... by Alla V. Marukhlenko, Mariya A. Morozova, Arsène M. J. Mbarga, Nadezhda V. Antipova, Anton V. Syroeshkin, Irina V. Podoprigora, Tatiana V. Maksimova
Published 2022-08-01
Article -
3
Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2 by Nadezhda V. Antipova, Tatyana D. Larionova, Andrei E. Siniavin, Maria A. Nikiforova, Vladimir A. Gushchin, Igor I. Babichenko, Alexey V. Volkov, Michail I. Shakhparonov, Marat S. Pavlyukov
Published 2020-12-01
Article -
4
The Nitro Group Reshapes the Effects of Pyrido[3,4-<i>g</i>]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells by Sophia S. Borisevich, Tatiana E. Aksinina, Margarita G. Ilyina, Victoria O. Shender, Ksenia S. Anufrieva, Georgij P. Arapidi, Nadezhda V. Antipova, Fabrice Anizon, Yannick J. Esvan, Francis Giraud, Victor V. Tatarskiy, Pascale Moreau, Mikhail I. Shakhparonov, Marat S. Pavlyukov, Alexander A. Shtil
Published 2024-02-01
Article -
5
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma by Anne V. Yagolovich, Alina A. Isakova, Artem A. Artykov, Yekaterina V. Vorontsova, Diana V. Mazur, Nadezhda V. Antipova, Marat S. Pavlyukov, Mikhail I. Shakhparonov, Anastasia M. Gileva, Elena A. Markvicheva, Ekaterina A. Plotnikova, Andrey A. Pankratov, Mikhail P. Kirpichnikov, Marine E. Gasparian, Dmitry A. Dolgikh
Published 2022-10-01
Article